I spearheaded strategic clinical development programs and formulated phase 1 clinical study protocols to advance our CAR T therapeutic. I've also played a pivotal role in aligning clinical programs with core corporate objectives through the development of target product profiles (TPPs).I've taken a hands-on approach implementing robust clinical study management practices. My knowledge dissemination through industry publications and presentations underscores my commitment to sharing insights and best practices.In data management and statistics, I've adhered to industry standards and benchmarked against FDA-approved CAR T therapeutics. My proficiency extends to project management, stakeholder alignment, and thorough industry and competitor analysis, all geared towards successful program management and commercial success.These experiences highlight my dedication to practical outcomes in an industry where precision and strategic alignment are key to success.

With a versatile skill set spanning clinical oversight, stakeholder management, operations management, regulatory compliance, financial management, and legal contract management expertise, I bring a comprehensive approach to organizational success. I've excelled in securing approvals for pivotal clinical studies, managing intricate contracts, and optimizing financial processes for cost-efficiency.My collaborative approach extends to working with medical advisors, scientific advisory board and third-party partners, contributing to clinical programs, and forging strong partnerships. In project management, I've successfully overseen complex legal re-domiciliation efforts and collaborated on advanced pricing agreements with tax authorities, requiring significant data analysis, driving growth and fundraising efforts.In legal matters, I've drafted contracts that mitigate our legal risk and efficiently managed an intellectual property portfolio resulting in strategic alignment. My financial management has streamlined operations, secured R&D tax rebates, and documented comprehensive transfer pricing documentation. I've maintained strict regulatory compliance and corporate governance standards for Australian and UK entities in company secretarial roles.

mobiLIFE developed a patented ambulatory infusion pump and operated a TGA-approved antibiotic compounding facility for hospital-in-the-home programs throughout Australia.Drove organisational change and business process improvement, while collaborating with leadership to transition from a device-centric model to a service-oriented strategy which significantly expanded our local area health network revenue and support. My strategic counsel and collaborative efforts with the CEO contributed to the successful acquisition of mobiLIFE by Slade Health in 2017.

I've demonstrated expertise in contract documentation, managing complex commercial budgets and negotiations, and drafting a range of agreements to advance our commercial interests while ensuring regulatory compliance and mitigating legal risks. My role in stakeholder management has involved offering strategic guidance in corporate governance, risk management, and compliance, contributing to business expansion while minimizing legal exposure. Additionally, I've played a key role in safeguarding our brand assets and commercial innovations through advising on intellectual property matters, including trademark and patent registrations. Furthermore, I've collaborated effectively with cross-functional teams to structure and execute complex financing transactions, including debt and equity offerings, facilitating our financial objectives.

In my global role overseeing a cross-border portfolio, I've cultivated robust stakeholder relationships and new business development opportunities through effective management and communication. My expertise includes successfully structuring and co-leading diverse equity and debt financing deals, spanning various sectors and deal sizes. I've provided comprehensive financial modelling and operational analytics and due diligence, contributing invaluable insights crucial for informed investment decisions in both Australian and international companies.I've been instrumental in stakeholder management, partnering with portfolio company boards and management teams in business planning to enhance financial and operational performance, as well as participating in the execution of a successful FDA IND-enabled phase 1 oncology clinical study. In addition to my financial controller and accounting role in an Australian retail business, I've also demonstrated my skills in project management by seamlessly coordinating a challenging office relocation project and formulated an outsourced manufacturing strategy of an FMCG product ranged in Walmart and Ulta Beauty.